drugset / Trial / NCT04002661
Hypoactive Sexual Desire Disorder in Males
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to determine if the study drug will increase sexual desire in men with HSDD. Half of the participants will take ADDYI while the other half will receive a placebo (a look-alike pill with no medicine).
Timeline
- Start
- 2020-05-08
- Primary completion
- 2025-10-31
- Completion
- 2026-01-23
Outcome
Outcome not reported
Stopped (Enrollment): “The study's inclusion and exclusion criteria are tight and could not enroll any patients”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | flibanserin | Small molecule | 100 mg | Oral |